Astex announces merger with metaGen Pharmaceuticals GmbH and improves cash position by �23m
31. Oktober 2003 01:40 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Oct. 31, 2003 (PRIMEZONE) -- Astex Technology Ltd, the fragment-based drug discovery company, today announced that it is to merge with Berlin-based oncology specialist, metaGen...
Astex achieves milestone in Alzheimer's drug discovery collaboration with AstraZeneca
22. September 2003 04:14 ET
|
Astex Therapeutics
CAMBRIDGE, United Kingdom, Sept. 22, 2003 (PRIMEZONE) -- Astex Technology, (Other OTC:FJSPF) the fragment-based drug discovery company, today announced that it has received the first research and...
Astex and Fujisawa announce structure-based drug discovery agreement
19. August 2003 01:18 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., August 19, 2003 (PRIMEZONE) -- Astex Technology Ltd, the fragment-based drug discovery company, and Fujisawa Pharmaceutical Co., Ltd, (Other OTC:FJSPF) today announced a structural...
Astex Technology's new research and development facility
11. Juli 2003 10:35 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., July 11, 2003 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced the official opening of its new, 36,000 ft2 research and development...
Astex Extends Research Collaboration with AstraZeneca
07. Juli 2003 04:06 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., July 7, 2003 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced that it has extended its existing research collaboration agreement with...
Astex Discovers Novel Form of a Key Protein Implicated in Diabetes and Obesity
12. Juni 2003 04:09 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., June 12, 2003 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced that its scientists have made a major discovery relating to a key protein...
Astex and Schering AG Announce Multi-Target Drug Discovery Alliance with Focus on Cancer Drugs
06. Mai 2003 02:59 ET
|
Astex Therapeutics
CAMBRIDGE, United Kingdom, May 6, 2003 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company and Schering AG (FSE:SCH) NYSE:SHR), today announced a major multi-target drug...
Astex Announces Drug Discovery Collaboration with the Institute of Cancer Research and Cancer Research Technology
20. März 2003 03:29 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., March 20, 2003 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced an exclusive research collaboration and licence agreement with the...
Astex Announces Alzheimer's Drug Discovery Collaboration with AstraZeneca
03. März 2003 03:14 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., March 3, 2003 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced a collaboration with AstraZeneca. The agreement relates to the discovery of...
Astex Appoints Director of Medicinal Chemistry
22. Januar 2003 03:42 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Jan. 22, 2003 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced the appointment of Dr. David Rees to the position of Director of Medicinal...